Ways to fit a PK model with some data below the quantification limit

被引:884
|
作者
Beal, SL [1 ]
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
关键词
model fitting; quantification limit; censored data;
D O I
10.1023/A:1012299115260
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacokinetic data consist of drug concentration measurements, as well as reports of some measured concentrations being below the quantification limit of the assay (BQL). A pharmacokinetic model may befit to these data, and for this purpose, them BQL observations must be either discarded or handled in a special way. In this paper, seven methods,for dealing with BQL observations are evaluated. Both single-subject and population data are simulated from a one-compartment model. A moderate amount of data is simulated for each individual. The actual cv of concentration measurements at the quantification limit is assumed to be no greater than 20%, in accord with the FDA Guidance, The results of this paper should be interpreted in this context. The methods include handling BQL observations as fixed-point censored observations, i.e., by using the likelihoods that these observations are in fact BQL. This method is shown to have some overall statistical advantage. However, the gain in using this method over that of simply discarding the BQL observations is not always much, and this is especially so when the frequency of BQL observations is small. Some simple methods entailing (i) replacing one or more BQL observations with the value 0, or (ii) replacing them with the value QL/2, where QL is the quantification limit, are also included. The first of these two approaches should not be used. With population data, use of the second approach can result in some noticeably improved estimation of the typical value of a parameter, but then there is also marked degradation in the estimation of the population variance of the parameter.
引用
收藏
页码:481 / 504
页数:24
相关论文
共 50 条
  • [41] Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification
    Thi Huyen Tram Nguyen
    Thu Thuy Nguyen
    Mentre, France
    PHARMACEUTICAL RESEARCH, 2017, 34 (10) : 2119 - 2130
  • [42] Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification
    Thi Huyen Tram Nguyen
    Thu Thuy Nguyen
    France Mentré
    Pharmaceutical Research, 2017, 34 : 2119 - 2130
  • [43] Methods for Non-Compartmental Pharmacokinetic Analysis With Observations Below the Limit of Quantification
    Barnett, Helen Yvette
    Geys, Helena
    Jacobs, Tom
    Jaki, Thomas
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2021, 13 (01): : 59 - 70
  • [44] Evaluation of pharmacokinetic studies: Is it useful to take into account concentrations below the limit of quantification?
    Humbert, H
    Cabiac, MD
    Barradas, J
    Gerbeau, C
    PHARMACEUTICAL RESEARCH, 1996, 13 (06) : 839 - 845
  • [45] Inferring the distribution of norovirus in individual oysters below the limit of quantification by pooled sampling
    Wang, Jianxin
    Zhou, Chen
    Wang, Yeru
    RISK ANALYSIS, 2024, 44 (05) : 1183 - 1192
  • [46] Pk-fit: A pharmacokinetic/pharmacodynamic and statistical data analysis software
    Farenc, C
    Fabreguette, JR
    Bressolle, F
    COMPUTERS AND BIOMEDICAL RESEARCH, 2000, 33 (05): : 315 - 329
  • [47] Use of Observations below Detection Limit for Model Calibration
    LeFrancois, Michael
    Poeter, Eileen
    GROUND WATER, 2009, 47 (02) : 228 - 236
  • [48] Likelihood based approaches to handling data below the quantification limit using NONMEM VI (vol 35, pg 401, 2008)
    Ahn, Jae Eun
    Karlsson, Mats O.
    Dunne, Adrian
    Ludden, Thomas M.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (03) : 305 - 308
  • [49] Quality quandaries: Impact of only below limit of detection data
    Hamada, M. S.
    Weaver, B. P.
    Schmidt, C. C.
    QUALITY ENGINEERING, 2016, 28 (03) : 358 - 364
  • [50] Use of Pharmacokinetic Data Below Lower Limit of Quantitation Values
    Jusko, William J.
    PHARMACEUTICAL RESEARCH, 2012, 29 (09) : 2628 - 2631